CareRx Corporation

TSX:CRRX Stock Report

Market Cap: CA$123.5m

CareRx Future Growth

Future criteria checks 0/6

CareRx is forecast to grow earnings and revenue by 29.1% and 3.2% per annum respectively while EPS is expected to grow by 120% per annum.

Key information

29.1%

Earnings growth rate

120.0%

EPS growth rate

Consumer Retailing earnings growth6.0%
Revenue growth rate3.2%
Future return on equityn/a
Analyst coverage

Good

Last updated12 Nov 2024

Recent future growth updates

Analyst Estimates: Here's What Brokers Think Of CareRx Corporation (TSE:CRRX) After Its Second-Quarter Report

Aug 11
Analyst Estimates: Here's What Brokers Think Of CareRx Corporation (TSE:CRRX) After Its Second-Quarter Report

Recent updates

CareRx (TSE:CRRX) Seems To Use Debt Quite Sensibly

Oct 03
CareRx (TSE:CRRX) Seems To Use Debt Quite Sensibly

Analyst Estimates: Here's What Brokers Think Of CareRx Corporation (TSE:CRRX) After Its Second-Quarter Report

Aug 11
Analyst Estimates: Here's What Brokers Think Of CareRx Corporation (TSE:CRRX) After Its Second-Quarter Report

Does CareRx (TSE:CRRX) Have A Healthy Balance Sheet?

Apr 22
Does CareRx (TSE:CRRX) Have A Healthy Balance Sheet?

Market Participants Recognise CareRx Corporation's (TSE:CRRX) Revenues Pushing Shares 28% Higher

Mar 17
Market Participants Recognise CareRx Corporation's (TSE:CRRX) Revenues Pushing Shares 28% Higher

CareRx (TSE:CRRX) Takes On Some Risk With Its Use Of Debt

Oct 19
CareRx (TSE:CRRX) Takes On Some Risk With Its Use Of Debt

What You Can Learn From CareRx Corporation's (TSE:CRRX) P/S

Aug 22
What You Can Learn From CareRx Corporation's (TSE:CRRX) P/S

CareRx (TSE:CRRX) Has A Somewhat Strained Balance Sheet

Sep 22
CareRx (TSE:CRRX) Has A Somewhat Strained Balance Sheet

These 4 Measures Indicate That CareRx (TSE:CRRX) Is Using Debt Extensively

May 14
These 4 Measures Indicate That CareRx (TSE:CRRX) Is Using Debt Extensively

Here's Why CareRx (TSE:CRRX) Has A Meaningful Debt Burden

Jan 21
Here's Why CareRx (TSE:CRRX) Has A Meaningful Debt Burden

Is CareRx Corporation's (TSE:CRRX) Shareholder Ownership Skewed Towards Insiders?

Mar 15
Is CareRx Corporation's (TSE:CRRX) Shareholder Ownership Skewed Towards Insiders?

Trade Alert: The Chairman Emeritus Of CareRx Corporation (TSE:CRRX), Jack Shevel, Has Just Spent CA$850k Buying 9.4% More Shares

Feb 08
Trade Alert: The Chairman Emeritus Of CareRx Corporation (TSE:CRRX), Jack Shevel, Has Just Spent CA$850k Buying 9.4% More Shares

Earnings and Revenue Growth Forecasts

TSX:CRRX - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2027389-2N/AN/A1
12/31/2026398-3N/AN/A4
12/31/2025380-417238
12/31/2024365-327338
9/30/2024366-63138N/A
6/30/2024367-72734N/A
3/31/2024369-42332N/A
12/31/2023371-51927N/A
9/30/2023374-62533N/A
6/30/2023378-73038N/A
3/31/2023380-341629N/A
12/31/2022382-34922N/A
9/30/2022384-34-411N/A
6/30/2022358-36-510N/A
3/31/2022311-20-18N/A
12/31/2021263-2307N/A
9/30/2021212-2127N/A
6/30/2021187-24-6-3N/A
3/31/2021177-29-20N/A
12/31/2020162-18-20N/A
9/30/2020148-50-3-1N/A
6/30/2020134-47-20N/A
3/31/2020126-34-12N/A
12/31/2019125-4636N/A
9/30/2019122-19-13N/A
6/30/2019119-20-24N/A
3/31/2019117-3959N/A
12/31/2018119-3527N/A
9/30/201885-27814N/A
6/30/201897-23N/A12N/A
3/31/2018110-3N/A15N/A
12/31/2017122-4N/A16N/A
9/30/2017168-6N/A14N/A
6/30/2017170-3N/A24N/A
3/31/2017170-13N/A10N/A
12/31/2016167-18N/A2N/A
9/30/2016166-21N/A6N/A
6/30/2016166-34N/A3N/A
3/31/2016164-30N/A20N/A
12/31/2015161-35N/A29N/A
9/30/201527-47N/A28N/A
6/30/201560-48N/A22N/A
3/31/201597-49N/A18N/A
12/31/2014135-44N/A20N/A
9/30/2014301-48N/A23N/A
6/30/2014295-43N/A26N/A
3/31/2014289-49N/A24N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CRRX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CRRX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CRRX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CRRX's revenue (3.2% per year) is forecast to grow slower than the Canadian market (7% per year).

High Growth Revenue: CRRX's revenue (3.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CRRX's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 02:54
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CareRx Corporation is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Doug CooperBeacon Securities Limited
David MartinBloom Burton & Co.
Prasath PanduranganBloom Burton & Co.